Core Viewpoint - Zhongwei Co., Ltd. (中伟股份) is undergoing a listing hearing on the Hong Kong Stock Exchange, with Morgan Stanley and Huatai International as joint sponsors [1] Company Overview - Zhongwei Co., Ltd. is an innovative new energy materials company focused on the research, development, production, and sales of precursor materials for positive active materials (pCAM) used in new energy batteries, as well as new energy metal products [2][3] - The company employs a vertically integrated business model, offering a comprehensive product matrix that includes nickel-based, cobalt-based, phosphorus-based, sodium-based, and other innovative new energy battery materials [3] Market Position - Zhongwei Co., Ltd. holds a leading global position in the supply of nickel-based and cobalt-based pCAM for lithium-ion batteries, ranking first in shipment volume for five consecutive years since 2020 [3] - For 2024, the company is projected to capture 20.3% and 28.0% of the market share for nickel-based and cobalt-based pCAM, respectively, and 21.8% of the total sales value of all pCAM products globally [3] Revenue and Financial Performance - The company's revenue for the years 2022, 2023, 2024, and the first half of 2025 is approximately 30.34 billion RMB, 34.27 billion RMB, 40.22 billion RMB, and 21.32 billion RMB, respectively [4][5] - The annual profit for the same periods is approximately 1.54 billion RMB, 2.10 billion RMB, 1.79 billion RMB, and 705.65 million RMB [4][5] Global Presence and Supply Chain - Zhongwei Co., Ltd. has established a global supply chain to secure high-quality and cost-effective resources, including nickel, phosphorus, and lithium, enhancing business resilience [4] - As of June 30, 2025, the company operates four production bases in China, three in Indonesia, one in Morocco, and plans to establish additional bases in Indonesia and South Korea [4] Customer Base - The revenue from direct customers outside of China has increased significantly, accounting for 33.7%, 41.1%, 44.5%, 45.4%, and 50.6% of total revenue from 2022 to the first half of 2025, indicating strong global recognition of the company's products [3]
新股消息 | 中伟股份(300919.SZ)通过港交所聆讯 pCAM产品销售价值排名全球第一